Figure 1. Abnormal expression of EphA2 in colorectal cancer and its relationship with prognosis. (A) Analysis of EphA2 mRNA and protein expression in colorectal cancer tissues and normal tissues using the UALCAN database. (B) Analysis of EphA2 mRNA expression in colorectal cancer tissues and normal tissues using the GEO database. (C) EphA2 expression data from HPA database in colorectal cancer tissues and normal tissues. (D) Overall survival of colorectal patients with differential EphA2 expression. (E, F) Correlation of EphA2 expression with MSI and TMB in colorectal cancer patients.